Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hip troubles: new study reveals how they change your posture and balance

NCT ID NCT06851793

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 110 adults with different hip problems, such as arthritis or labral tears, to understand how these conditions affect posture, muscle strength, balance, pain, and quality of life. Researchers used special 3D imaging and pain tests to measure these factors. The goal was to gather knowledge about how various hip issues impact the body, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

110 people

The number who actually took part.

Started

Oct 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals with different hip pathologies (hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, hip avascular necrosis) who volunteered the participate the study

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being diagnosed with any of the following: hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, hip avascular necrosis. * Having mechanical impact on the hip joint * Symptoms have been ongoing for at least 6 months * Being between the ages of 18-65 Exclusion Criteria: * Being diagnosed with scoliosis by a physician * Being diagnosed with any developmental disorder (Scheuermann's/Calve Disorder etc.), * Being diagnosed with a neurological and/or cognitive disease that may affect cognitive functions * Being diagnosed with Inflammatory Arthritis * Having undergone surgery on the spine and extremities, * Getting diagnosed with Infection (Spinal Tuberculosis etc.), Tumor (Multiple Myeloma) * Epilepsy, Antidepressant / Attention enhancing drug use

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip avascular necrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hacettepe University

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.